Literature DB >> 17393454

Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.

Karen H Costenbader1, Diane Feskanich, Meir J Stampfer, Elizabeth W Karlson.   

Abstract

OBJECTIVE: Systemic lupus erythematosus (SLE) occurs predominantly in women, and hormones may play a role in its etiology. This study was carried out to examine associations between female reproductive and menopausal factors and the development of SLE.
METHODS: A cohort of 238,308 women was prospectively examined. Subjects were older women (ages 30-55 years at start) and younger women (ages 25-42 years at start) from the Nurses' Health Study (NHS) and NHSII cohorts. Incident SLE diagnosed between 1976 and 2003 was confirmed by medical record review. The relative risk (RR) of SLE was estimated separately in each cohort using Cox proportional hazards models, and then pooled using meta-analysis random effects models.
RESULTS: Two hundred sixty-two incident cases of SLE were confirmed among the women. In multivariable models adjusted for reproductive and other risk factors, age<or=10 years at menarche (pooled RR 2.1, 95% confidence interval [95% CI] 1.4-3.2), oral contraceptive use (pooled RR 1.5, 95% CI 1.1-2.1), and use of postmenopausal hormones (RR 1.9, 95% CI 1.2-3.1) significantly increased the risk of SLE. An elevation of SLE risk was observed among postmenopausal women primarily after surgical menopause (RR 2.3, 95% CI 1.2-4.5), and also among women with earlier age at natural menopause (P for trend<0.05). Menstrual irregularity was associated with an increased risk of SLE among women in the younger (NHSII) cohort. Age at first birth, parity, and total duration of breastfeeding were not associated with SLE.
CONCLUSION: Early age at menarche, oral contraceptive use, early age at menopause, surgical menopause, and postmenopausal use of hormones were each associated with an increased risk of SLE. These associations may point to the mechanisms underlying the pathogenesis of SLE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393454     DOI: 10.1002/art.22510

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  102 in total

Review 1.  Risk factors of systemic lupus erythematosus flares during pregnancy.

Authors:  Luis J Jara; Gabriela Medina; Pilar Cruz-Dominguez; Carmen Navarro; Olga Vera-Lastra; Miguel A Saavedra
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Paediatric rheumatic disease: lessons from SLE: children are not little adults.

Authors:  Stacy P Ardoin; Laura E Schanberg
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

3.  Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women.

Authors:  Karen H Costenbader; Jae Hee Kang; Elizabeth W Karlson
Journal:  Am J Epidemiol       Date:  2010-06-09       Impact factor: 4.897

Review 4.  Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.

Authors:  Grant C Hughes; Divaker Choubey
Journal:  Nat Rev Rheumatol       Date:  2014-08-26       Impact factor: 20.543

5.  Lupus: an overview of the disease and management options.

Authors:  William Maidhof; Olga Hilas
Journal:  P T       Date:  2012-04

Review 6.  Endometriosis: a high-risk population for major chronic diseases?

Authors:  Marina Kvaskoff; Fan Mu; Kathryn L Terry; Holly R Harris; Elizabeth M Poole; Leslie Farland; Stacey A Missmer
Journal:  Hum Reprod Update       Date:  2015-03-11       Impact factor: 15.610

7.  Hormone therapy increases risk of ulcerative colitis but not Crohn's disease.

Authors:  Hamed Khalili; Leslie M Higuchi; Ashwin N Ananthakrishnan; JoAnn E Manson; Diane Feskanich; James M Richter; Charles S Fuchs; Andrew T Chan
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

8.  Childhood abuse and early menarche: findings from the black women's health study.

Authors:  Lauren A Wise; Julie R Palmer; Emily F Rothman; Lynn Rosenberg
Journal:  Am J Public Health       Date:  2009-05-14       Impact factor: 9.308

Review 9.  [Sex-specific differences of the immune system].

Authors:  G Riemekasten; E Siegert
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

Review 10.  Belimumab in systemic lupus erythematosus: a perspective review.

Authors:  Joyce S Hui-Yuen; Xiao Q Li; Anca D Askanase
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-08       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.